Analyst Reco. Edwards Lifesciences Corporation

Stocks

EW

US28176E1082

Advanced Medical Equipment & Technology

Market Closed - NYSE Other stock markets 04:00:03 13/06/2026 HKT			5-day change	1st Jan Change
85.11 ^USD	-0.76%		-0.99%	-0.16%

06-11	Edwards Lifesciences Set to Benefit from TAVR Coverage Update, RBC Says	MT
06-02	TD Cowen Adjusts Price Target on Edwards Lifesciences to $104 From $97, Maintains Buy Rating	MT

Analyst Reco.

06-11	Edwards Lifesciences Set to Benefit from TAVR Coverage Update, RBC Says	MT
06-02	TD Cowen Adjusts Price Target on Edwards Lifesciences to $104 From $97, Maintains Buy Rating	MT
04-28	Rothschild & Co Redburn Adjusts Price Target on Edwards Lifesciences to $99 From $94, Maintains Buy Rating	MT
04-24	Mizuho Securities Adjusts Edwards Lifesciences Price Target to $100 From $95, Maintains Outperform Rating	MT
04-24	Truist Securities Adjusts Price Target on Edwards Lifesciences to $90 From $89, Maintains Hold Rating	MT
04-24	Bernstein Adjusts PT on Edwards Lifesciences to $96 From $95, Maintains Market Perform Rating	MT
04-24	Canaccord Genuity Adjusts PT on Edwards Lifesciences to $85 From $87, Maintains Hold Rating	MT
04-24	Barclays Adjusts PT on Edwards Lifesciences to $110 From $104, Maintains Overweight Rating	MT
04-24	Evercore ISI Adjusts PT on Edwards Lifesciences to $93 From $92, Maintains Outperform Rating	MT
04-24	Baird Adjusts Price Target on Edwards Lifesciences to $87 From $85, Maintains Neutral Rating	MT
04-24	BTIG Adjusts Price Target on Edwards Lifesciences to $100 From $98, Maintains Buy Rating	MT
04-24	Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $98 From $97, Maintains Buy Rating	MT
04-15	Baird Adjusts Price Target on Edwards Lifesciences to $85 From $87, Maintains Neutral Rating	MT
04-14	BTIG Research Adjusts Edwards Lifesciences Price Target to $98 From $103, Maintains Buy Rating	MT
04-13	Mizuho Adjusts Price Target on Edwards Lifesciences to $95 From $100, Maintains Outperform Rating	MT
04-08	Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $97 From $95, Maintains Buy Rating	MT
04-06	Evercore ISI Adjusts Edwards Lifesciences PT to $92 From $94, Maintains Outperform Rating	MT
04-02	Edwards Lifesciences Shares Rise After Wolfe Research Upgrade	MT
04-01	Wolfe Research Upgrades Edwards Lifesciences to Outperform From Peer Perform, Price Target is $92	MT
02-24	Daiwa Securities Adjusts Price Target on Edwards Lifesciences to $98 From $99, Maintains Buy Rating	MT
02-13	UBS Adjusts Edwards Lifesciences Price Target to $90 From $94, Maintains Neutral Rating	MT
02-12	Rothschild & Co Redburn Adjusts Edwards Lifesciences PT to $94 From $93, Maintains Buy Rating	MT
02-12	Edwards Lifesciences 2026 Growth Targets Achievable, RBC Says	MT
02-12	Truist Securities Adjusts Price Target on Edwards Lifesciences to $89 From $92, Maintains Hold Rating	MT
02-11	Piper Sandler Adjusts Price Target on Edwards Lifesciences to $100 From $98, Maintains Overweight Rating	MT